Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
107.17
-2.53 (-2.31%)
Mar 28, 2025, 3:05 PM EDT - Market open
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 68 employees as of December 31, 2024. The number of employees increased by 10 or 17.24% compared to the previous year.
Employees
68
Change (1Y)
10
Growth (1Y)
17.24%
Revenue / Employee
$2,457,838
Profits / Employee
-$59,294
Market Cap
2.06B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LGND News
- 25 days ago - Ligand to Participate in March Investor Conferences - GlobeNewsWire
- 4 weeks ago - Ligand Pharmaceuticals Incorporated (LGND) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Ligand Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences - GlobeNewsWire
- 6 weeks ago - Ligand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Business Wire
- 7 weeks ago - Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
- 7 weeks ago - Looking Back On Ligand Pharmaceuticals - Seeking Alpha
- 2 months ago - Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha